Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020



Stephen Ward

Stephen Ward

Chief Manufacturing Officer, Cell and Gene Therapy Catapult

Prior to becoming the new Chief Manufacturing Officer of the Cell and Gene Therapy Catapult Stephen has established the world-class industrialisation capabilities at both the Guy’s Hospital facilities in London, plus designed and built the innovative GMP Manufacturing Centre in Stevenage. As the first Chief Operating Officer of CGT Stephen brings over 25 years of biological medicine research, development, and manufacturing experience to the organisation. Stephen enjoys bringing high impact therapies to patients, by developing commercially viable products.  Stephen is passionate about securing and growing the cell and gene therapy manufacturing and development supply chain.  He is the current Chair of the BIA’s Manufacturing Advisory Committee, actively promoting and supporting UK biomanufacturing at Government as well as grass root level. His first degree was from the University of Birmingham, and his second degree from the Medical School of Southampton University.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd